Events Add an event Speakers Talks Collections
 

Speakers

Sort by
Newest
Trending
1-30 of 34
1-30 of 34
Filter
Natan Ponieman
Staff Writer at Benzinga
antidepressant, attention deficit hyperactivity disorder, benzinga cannabis , benzinga news, bioavailability, brand, cactus, cannabidiol, cannabis conference 2021, cannabis earnings, cannabis entrepreneurs , cannabis industry, cannabis organizations, cannabis sales, canopy growth, carbonated water, constellation brands, conversation, covid-19 pandemic, cucumber, dopamine, drink, drug, drug liberalization, dvd, ginger, guava, health care, health professional, hemp, highest quality cannabis, hope, major depressive disorder, martha stewart, mdma, medical cannabis, medication, mental disorder, mentha, microdosing therapies, money, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic therapy, psychedelics, psychologist, psychology, psychotherapy, receptor antagonist, science, serotonin, stock prices, sugar, tetrahydrocannabinol, trading strategies, trading strategies cannabis, united states, universe, veteran, washing machine, water, wine
Sylvia Jablonski
Chief Investment Officer at Definance ETFs
antidepressant, attention deficit hyperactivity disorder, benzinga cannabis , benzinga news, bioavailability, cannabis conference 2021, cannabis entrepreneurs , conversation, dopamine, drug, drug liberalization, health care, health professional, hemp, hope, major depressive disorder, mdma, medical cannabis, medication, mental disorder, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic therapy, psychedelics, psychologist, psychology, psychotherapy, receptor antagonist, serotonin, stock prices, veteran
James Lanthier
CEO at Mindset Pharma
antidepressant, attention deficit hyperactivity disorder, benzinga cannabis , benzinga news, bioavailability, cannabis conference 2021, cannabis entrepreneurs , conversation, dopamine, drug, drug liberalization, health care, health professional, hemp, hope, major depressive disorder, mdma, medical cannabis, medication, mental disorder, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic therapy, psychedelics, psychologist, psychology, psychotherapy, receptor antagonist, serotonin, stock prices, veteran
Hugh Rogers
Director and CEO at XPhyto Therapeutics
antidepressant, attention deficit hyperactivity disorder, benzinga cannabis , benzinga news, bioavailability, cannabis conference 2021, cannabis entrepreneurs , conversation, dopamine, drug, drug liberalization, health care, health professional, hemp, hope, major depressive disorder, mdma, medical cannabis, medication, mental disorder, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic therapy, psychedelics, psychologist, psychology, psychotherapy, receptor antagonist, serotonin, stock prices, veteran
Joseph Tucker
President & CEO at MagicMed Industries
cannabis event 2021, cannabis stocks and options, antidepressant, attention deficit hyperactivity disorder, benzinga cannabis , benzinga news, bioavailability, biotechnology, cannabinoid, cannabis conference 2021, cannabis earnings, cannabis entrepreneurs , cannabis hedge funds, cannabis investments, cannabis investor presentation , chemical substance, chemistry, clinical trial, conversation, dopamine, drug, drug development, drug discovery, drug liberalization, enzyme, experience, first-mover advantage, hallucination, health care, health professional, hemp, highest quality cannabis, hope, investor, library, lysergic acid diethylamide, major depressive disorder, marijuana, mdma, medical cannabis, medication, mental disorder, mental health, mescaline, pharmaceutical industry, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychedelic therapy, psychedelics, psychologist, psychology, psychotherapy, receptor antagonist, science, serotonin, stock prices, synthetic biology, veteran
Rae Elkasabany
FTIR Program Coordinator at DanceSafe
billboard, cigarette, community, conversation, curriculum, dancesafe, drug checking, drug education, drug policy, education, erowid, harm reduction, health, history, just say no, mdma, mental disorder, mental health, psychedelic experience, public health, reason, smoking, students for sensible drug policy, substance abuse, tobacco smoking
Kevin Garcia
Harm Reduction Content Expert at NEXT Distro
billboard, cigarette, community, conversation, curriculum, dancesafe, drug checking, drug education, drug policy, education, erowid, harm reduction, health, history, just say no, mdma, mental disorder, mental health, psychedelic experience, public health, reason, smoking, students for sensible drug policy, substance abuse, tobacco smoking
Haley Dourron
Doctoral Student at University of Alabama at Birmingham
billboard, cigarette, community, conversation, curriculum, dancesafe, drug checking, drug education, drug policy, education, erowid, harm reduction, health, history, just say no, mdma, mental disorder, mental health, psychedelic experience, public health, reason, smoking, students for sensible drug policy, substance abuse, tobacco smoking
Vanessa Grifford
Business Center Representative at CopperPoint Mutual Insurance Company
behavioral neuroscience, clinical trial, communication, computer science, consciousness, education, engineering, goal, health, internet, learning, mdma, medical school, memory, mental disorder, mental health, mentorship, mind, psychedelic therapy, psychology, reed college, science, software , students for sensible drug policy, theory
Azhar Ahmad
Software Engineer Consultant at Slalom
behavioral neuroscience, clinical trial, communication, computer science, consciousness, education, engineering, goal, health, internet, learning, mdma, medical school, memory, mental disorder, mental health, mentorship, mind, psychedelic therapy, psychology, reed college, science, software , students for sensible drug policy, theory
Richard Hartnell
Director at OASIS
behavioral neuroscience, clinical trial, communication, computer science, consciousness, education, engineering, goal, health, internet, learning, mdma, medical school, memory, mental disorder, mental health, mentorship, mind, psychedelic therapy, psychology, reed college, science, software , students for sensible drug policy, theory
Wesley Hale
Training Program Manager at MAPS Public Benefit Corporation (MAPS PBC)
behavioral neuroscience, clinical trial, communication, computer science, consciousness, education, engineering, goal, health, internet, learning, mdma, medical school, memory, mental disorder, mental health, mentorship, mind, psychedelic therapy, psychology, reed college, science, software , students for sensible drug policy, theory
Vilmarie Fraguada Narloch
Director at Sana Healing Collective
behavioral neuroscience, clinical trial, communication, computer science, consciousness, education, engineering, goal, health, internet, learning, mdma, medical school, memory, mental disorder, mental health, mentorship, mind, psychedelic therapy, psychology, reed college, science, software , students for sensible drug policy, theory
Dustin Robinson
Founding Partner at Mr. Cannabis Law
advertising, angel investor, bank, canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), caregiver, clinical trial, commerce clause, dividend, dividend tax, doctor–patient relationship, dose (biochemistry), dronabinol, drug, economics, employment, evidence-based medicine, expense, flow-through entity, food and drug administration, franchising, innovation, interest, internal revenue service, investment, joe biden, jurisdiction, legality of cannabis, limited liability company, limited liability partnership, loan, major depressive disorder, market (economics), mdma, medical cannabis, medication, medicine, mergers and acquisitions, mergers, and acquisitions, multidisciplinary association for psychedelic studies, nevis, opioid, opium, over-the-counter drug, ownership, pain management, partnership, pharmacy, physician, prescription drug, price, psilocybin, psychedelic drug, rate of return, regulatory compliance, seed money, social stigma, supply chain, tax, tax rate, tetrahydrocannabinol, traditional chinese medicine, unemployment, valuation (finance)
Salimeh Tabrizi
Co-Founder at Canadian Psychedelic Association
alison draisin, alternative medicine, android (operating system), antipsychotic, awareness, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis and psychedelics, cannabis strain, consciousness, dr. dominic corva, dr. jim fadiman, dronabinol, entheogens, entropy, eric boone, forgiveness, hinduism, hypnosis, indian reservation, ios, mdma, medicine, meditation, mental disorder, mind, mobile app, monte levine, native american church, native americans in the united states, palliative care, physician, privacy, prohibition of drugs, psychedelic drug, psychedelic therapy, psychiatry, psychological trauma, psychotherapy, public spiritual health, relaxation (psychology), religion, religious experience, salimeh tabrizi, seattle hempfest 2020, seattle hempfest 2020 online, second law of thermodynamics, self, self-actualization, serotonin, shiva, spirituality, substance theory, sunil aggarwal, support for your mental health, terminal illness, tetrahydrocannabinol, yoga
James Fadiman
Senior Research Fellow at Sofia University
alison draisin, android (operating system), antipsychotic, cannabidiol, cannabinoid, cannabis (drug), cannabis and psychedelics, cannabis strain, dr. jim fadiman, dronabinol, entropy, eric boone, forgiveness, hypnosis, ios, mdma, meditation, mind, mobile app, privacy, psychedelic drug, psychedelic therapy, psychiatry, psychological trauma, psychotherapy, religious experience, salimeh tabrizi, seattle hempfest 2020 online, second law of thermodynamics, serotonin, support for your mental health, tetrahydrocannabinol
Alison Draisin
Psychologist at AIMS Institute
alison draisin, android (operating system), antipsychotic, cannabidiol, cannabinoid, cannabis (drug), cannabis and psychedelics, cannabis strain, dr. jim fadiman, dronabinol, entropy, eric boone, forgiveness, hypnosis, ios, mdma, meditation, mind, mobile app, privacy, psychedelic drug, psychedelic therapy, psychiatry, psychological trauma, psychotherapy, religious experience, salimeh tabrizi, seattle hempfest 2020 online, second law of thermodynamics, serotonin, support for your mental health, tetrahydrocannabinol
Jourdan Woltz
Owner at JADE Healing Co CBD
antidepressant, autism, belief, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis indica, cannabis sativa, cannabis strain, chromatography, dose (biochemistry), dronabinol, drug test, entourage effect, environmental remediation, ethanol, fertilizer, freeze-drying, health care, hexane, high-performance liquid chromatography, isopropyl alcohol, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, solution, substance dependence, supercritical carbon dioxide, supercritical fluid, tetrahydrocannabinol, treatment-resistant depression, water
Chip Paul
President & Co-Founder at GnuPharma
alternative medicine, alzheimer's disease, antidepressant, antipsychotic, appetite, autism, autoimmune disease, belief, bioavailability, bipolar disorder, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cattle feeding, certificate of analysis, chemotherapy, consumer protection, depression (mood), dietary supplement, docosahexaenoic acid, dopamine, dose (biochemistry), dronabinol, drug development, eating, eicosapentaenoic acid, emergency medical technician, emulsion, endocannabinoid system, endocrinology, epilepsy, fat, fibromyalgia, fish oil, food and drug administration, gpr55, health care, hormone, hunger (physiology), hypertension, hypothalamus, irritable bowel syndrome, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, nonverbal communication, norepinephrine, obesity, omega-3 fatty acid, omega-6 fatty acid, paracetamol, parkinson's disease, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, pharmacy, placebo, post-traumatic stress disorder, prescription drug, probiotic, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, serotonin, shelf life, sleep, substance dependence, synthetic cannabinoids, tablet (pharmacy), tetrahydrocannabinol, topical medication, traditional chinese medicine, treatment-resistant depression, triglyceride, trpv1, vitamin c, well-being
anti-inflammatory, antidepressant, aromatherapy, autism, behavior, belief, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis indica, cannabis sativa, dose (biochemistry), drink, dronabinol, entourage effect, essential oil, health care, herbal distillate, hindsight bias, juice, lemon, limonene, major depressive disorder, management of depression, mango, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, secondary metabolite, selective serotonin reuptake inhibitor, spectrum, substance dependence, terpene, terpenoid, tetrahydrocannabinol, treatment-resistant depression, water, water activity
Annie Epley
Director of Operations at From Soil to Soul, LLC
anti-inflammatory, antidepressant, aromatherapy, autism, behavior, belief, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis indica, cannabis sativa, dose (biochemistry), drink, dronabinol, entourage effect, essential oil, health care, herbal distillate, hindsight bias, juice, lemon, limonene, major depressive disorder, management of depression, mango, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, secondary metabolite, selective serotonin reuptake inhibitor, spectrum, substance dependence, terpene, terpenoid, tetrahydrocannabinol, treatment-resistant depression, water, water activity
Priscilla Agoncillo
Co-Founder at Original Breeders League
agriculture, anti-inflammatory, antidepressant, anxiolytic, autism, belief, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, clinical trial, consciousness, cotton, crispr, crispr gene editing, democratic party (united states), disease, dispensary, dna, dna sequencing, dominance (genetics), dose (biochemistry), dravet syndrome, dronabinol, education, emergency medical technician, endocannabinoid system, entourage effect, epilepsy, ethnobotany, food and drug administration, free market, gene, gene mapping, genetic engineering, genetically modified organism, genetics, genome, gerrymandering, good manufacturing practice, hair loss, hashish, health, health care, hemp, human genome, landrace, major depressive disorder, management of depression, mdma, mechanism of action, medical cannabis, medication, medicine, mental disorder, mental health, micropropagation, mood stabilizer, neuroplasticity, neurotransmitter, neutron, organism, paramedic, pediatrics, pharmaceutical industry, pharmacology, pharmacy, plant tissue culture, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychiatry, psychoactive drug, psychology, schizophrenia, science, selective serotonin reuptake inhibitor, sense, sequencing, serotonin, substance dependence, swing state, syndrome, tetrahydrocannabinol, tony montana, treatment-resistant depression, whole genome sequencing
Trey Tijerina
Owner at WhyPayTrey
advertising, antidepressant, audience measurement, audit, autism, avatar (computing), belief, blog, brand, brand awareness, cannabidiol, cannabinoid, cannabis, carbon dioxide, credibility, digital marketing, dose (biochemistry), dronabinol, facebook, false advertising, game balance, good manufacturing practice, google, google search, hashtag, health care, hemp, inbound marketing, instagram, internet, linkedin, major depressive disorder, management of depression, massage, mdma, medical cannabis, medicine, mental health, mood stabilizer, news, newspaper, pharmaceutical industry, pharmacy, podcast, product sample, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, publicist, publishing, radio advertisement, research, search engine optimization, selective serotonin reuptake inhibitor, small business, social media, social media marketing, social stigma, substance dependence, symbol, target market, testimonial, treatment-resistant depression, twitter, vlog, youtube
Robert W.E. Laurie
Advisory Board Member (MAPS Canada) at Multidisciplinary Association for Psychedelic Studies (MAPS)
2019, addiction, alcoholism, alternative, attorney general, bank, biohacking, biotech, blinded experiment, business, cambridge house, canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis (drug), cannabis act, capital, clinical trial, cognitive behavioral therapy, company, compass pathways, consciousness, controlled substance, coronavirus disease 2019, criminalization, dennis mckena, denver, dose (biochemistry), downtown eastside, drug, drug education, drug policy reform, education, entrepreneur, event, evidence-based medicine, extraordinary future, finance, food and drug administration, gabor mate, gabor maté (physician), hallucinogen, harm reduction, health care, holistic, ibogaine, johns hopkins university, jr rahn, jurisdiction, lars wilde, legality of cannabis, lysergic acid diethylamide, major depressive disorder, market, matthew johnson, mdma, medical cannabis, medication, medicine, mental health, micro dosing, mind, mindmed, money, monopoly, motivation, motivational interviewing, multidisciplinary association for psychedelic studies, mushrooms, nevis, opioid, opium, over-the-counter drug, panel, pardon, pharmacy, physician, placebo, prescription drug, prosecutor, psilocybin, psilocybin mushroom, psychedelics, psychotherapy, public, regulation of therapeutic goods, regulatory compliance, science, silicon valley, social control, spiritual, stock, substance abuse, tech, tetrahydrocannabinol, the doors of perception, therapy, tim ferriss, traditional chinese medicine, treatment, treatment-resistant depression, united states attorney, varenicline, war on drugs, xf
Dennis Mckena
Founding Partner at Lodbrok Capital LLP
2019, addiction, alcoholism, alternative, biohacking, biotech, blinded experiment, business, cambridge house, cannabis (drug), cannabis act, capital, cognitive behavioral therapy, company, compass pathways, consciousness, criminalization, dennis mckena, downtown eastside, entrepreneur, event, extraordinary future, finance, gabor mate, gabor maté (physician), hallucinogen, harm reduction, health care, holistic, ibogaine, johns hopkins university, jr rahn, lars wilde, lysergic acid diethylamide, major depressive disorder, market, matthew johnson, mdma, medicine, mental health, micro dosing, mind, mindmed, money, motivation, motivational interviewing, mushrooms, opioid, panel, placebo, psilocybin, psilocybin mushroom, psychedelics, psychotherapy, public, science, silicon valley, social control, spiritual, stock, substance abuse, tech, the doors of perception, therapy, tim ferriss, treatment, treatment-resistant depression, varenicline, xf
Matthew Johnson
Associate Professor at Johns Hopkins University School of Medicine
2019, addiction, adverse drug reaction, alcoholism, alternative, anorexia nervosa, bad trip, benzodiazepine, biohacking, biotech, blinded experiment, business, cambridge house, cannabis (drug), cannabis act, capital, cognitive behavioral therapy, company, compass pathways, consciousness, controlled substances act, criminalization, dennis mckena, downtown eastside, entrepreneur, event, extraordinary future, finance, gabor mate, gabor maté (physician), hallucinogen, harm reduction, health care, heroin, holistic, ibogaine, institute, johns hopkins university, jr rahn, lars wilde, lysergic acid diethylamide, major depressive disorder, market, matthew johnson, mdma, medicine, mental disorder, mental health, methadone, micro dosing, milken, mind, mindmed, money, motivation, motivational interviewing, mushrooms, n,n-dimethyltryptamine, nicotine, opioid, opioid epidemic in the united states, opioid use disorder, oxycodone/paracetamol, panel, placebo, psilocybin, psilocybin mushroom, psychedelic, psychedelics, psychiatry, psychological trauma, psychosis, psychotherapy, public, recreational drug use, schizophrenia, science, silicon valley, social control, spiritual, stock, substance abuse, substance dependence, tech, the doors of perception, therapy, tim ferris, tim ferriss, treatment, treatment-resistant depression, varenicline, xf
Lars Christian Wilde
President & Co-Founder at COMPASS Pathways
2019, addiction, alcoholism, alternative, biohacking, biotech, blinded experiment, business, cambridge house, cannabis (drug), cannabis act, capital, cognitive behavioral therapy, company, compass pathways, consciousness, criminalization, dennis mckena, downtown eastside, entrepreneur, event, extraordinary future, finance, gabor mate, gabor maté (physician), hallucinogen, harm reduction, health care, holistic, ibogaine, johns hopkins university, jr rahn, lars wilde, lysergic acid diethylamide, major depressive disorder, market, matthew johnson, mdma, medicine, mental health, micro dosing, mind, mindmed, money, motivation, motivational interviewing, mushrooms, opioid, panel, placebo, psilocybin, psilocybin mushroom, psychedelics, psychotherapy, public, science, silicon valley, social control, spiritual, stock, substance abuse, tech, the doors of perception, therapy, tim ferriss, treatment, treatment-resistant depression, varenicline, xf
JR Rahn
Founder & Co-CEO at MindMed
2019, addiction, alcoholism, alternative, biohacking, biotech, biotechnology, blinded experiment, business, cambridge house, cannabis (drug), cannabis act, capital, cognitive behavioral therapy, company, compass pathways, conference, consciousness, criminalization, dennis mckena, downtown eastside, drug development, drug discovery, eli lilly and company, entrepreneur, event, extraordinary future, finance, food and drug administration, gabor mate, gabor maté (physician), hallucinogen, harm reduction, health care, holistic, homelessness, ibogaine, investing, johns hopkins university, jr rahn, ketamine, lars wilde, lysergic acid diethylamide, magic mushrooms, major depressive disorder, market, matthew johnson, mdma, medication, medicine, mental health, mentorship, micro dosing, mind, mindmed, money, motivation, motivational interviewing, mushrooms, opioid, opioid epidemic in the united states, panel, pharmaceutical industry, phases of clinical research, placebo, psilocybin, psilocybin mushroom, psychedelic drug, psychedelics, psychotherapy, public, research, science, silicon valley, social control, spiritual, startup accelerator, startup company, stock, stocks, substance abuse, tech, the doors of perception, therapy, tim ferriss, time, treatment, treatment-resistant depression, varenicline, xf, y combinator
Charles Grob
Directior, Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center
anxiety, autism spectrum, clinical trial, disease, food and drug administration, hallucinogen, major depressive disorder, mdma, mental disorder, mental health, michael pollan, multidisciplinary association for psychedelic studies, phases of clinical research, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychedelic therapy, psychiatry, psychopharmacology, psychotherapy, startups, substance dependence, technology, the doors of perception, therapy, treatment of mental disorders, venture capital
Robert Jesse
Researcher, non-profit organizer at The Johns Hopkins University
anxiety, autism spectrum, clinical trial, disease, food and drug administration, hallucinogen, major depressive disorder, mdma, mental disorder, mental health, michael pollan, multidisciplinary association for psychedelic studies, phases of clinical research, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychedelic therapy, psychiatry, psychopharmacology, psychotherapy, startups, substance dependence, technology, the doors of perception, therapy, treatment of mental disorders, venture capital
1 2
1-30 of 34